Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 51 |
Massachusetts Financial Services
Boston,
Massachusetts
| $509M | -$43.4M | 6 | 0.14% | Reduced |
|
| 52 |
Nuveen
Charlotte,
North Carolina
| $489M | -$99.2M | 54 | 0.14% | Reduced |
|
| 53 |
Sands Capital Management
Arlington,
Virginia
| $483M | -$17.2M | 1 | 0.9% | Reduced |
|
| 54 |
BBA
Baker Bros. Advisors
New York
| $478M | +$42.1M | 18 | 2.32% | Increased |
|
| 55 |
Brown Advisory
Baltimore,
Maryland
| $466M | -$5.94M | 8 | 0.58% | Reduced |
|
| 56 |
Bellevue Group
Kuesnacht,
Switzerland
| $460M | +$95.4M | 11 | 4.75% | Increased |
|
| 57 |
Renaissance Technologies
New York
| $459M | +$110M | 55 | 0.57% | Increased |
|
| 58 |
D.E. Shaw & Co
New York
| $452M | +$270M | 50 | 0.38% | Increased |
|
| 59 |
Credit Suisse
Zurich,
Switzerland
| $450M | +$21.5M | 41 | 0.24% | Increased |
|
| 60 |
Avoro Capital Advisors
New York
| $448M | +$83.5M | 4 | 7.63% | Increased |
|
| 61 |
Royal Bank of Canada
Toronto,
Ontario, Canada
| $445M | -$22.8M | 83 | 0.1% | Reduced |
|
| 62 |
First Trust Advisors
Wheaton,
Illinois
| $432M | +$33.7M | 13 | 0.42% | Increased |
|
| 63 |
Parametric Portfolio Associates
Seattle,
Washington
| $432M | -$5.05M | 50 | 0.22% | Reduced |
|
| 64 |
OrbiMed
New York
| $430M | -$76.2M | 13 | 5.53% | Reduced |
|
| 65 |
Two Sigma Advisers
New York
| $428M | +$78.7M | 51 | 1.07% | Increased |
|
| 66 |
Marshall Wace
London,
United Kingdom
| $425M | +$206M | 51 | 0.79% | Increased |
|
| 67 |
William Blair Investment Management
Chicago,
Illinois
| $423M | +$61.3M | 2 | 1.14% | Increased |
|
| 68 |
APM
Avidity Partners Management
Dallas,
Texas
| $421M | +$48.3M | 11 | 8.93% | Increased |
|
| 69 |
Two Sigma Investments
New York
| $420M | +$86.9M | 52 | 0.9% | Increased |
|
| 70 |
Boston Partners
Boston,
Massachusetts
| $409M | +$24.3M | 1 | 0.49% | Increased |
|
| 71 |
Adage Capital Partners
Boston,
Massachusetts
| $404M | +$40.9M | 15 | 0.73% | Increased |
|
| 72 |
TimesSquare Capital Management
New York
| $401M | -$14.7M | 5 | 3.55% | Reduced |
|
| 73 |
EARNEST Partners
Atlanta,
Georgia
| $400M | -$79.2M | 5 | 2.31% | Reduced |
|
| 74 |
Fred Alger Management
New York
| $396M | +$63.3M | 8 | 0.99% | Increased |
|
| 75 |
RA Capital Management
Boston,
Massachusetts
| $382M | -$2.21M | 10 | 6.73% | Reduced |
|